|
|
350 Oak Grove Parkway
St. Paul, MN 55127 USA
phone:651-484-4874
fax:651-379-8227
|
|
| Symbol |
ANGN |
| Exchange |
Nasdaq |
| Founded |
1986 |
| Employees |
155 |
|
|
| www.angeion.com
|
|
| Research Sector |
Medical Devices & Tech |
|
 |
| Summary Description |
| Non-invasive cardio-respiratory diagnostic systems. |
|
| Management |
| Rodney A. Young, Chief Executive Officer & President; William J. Kullback, Senior Vice President and Chief Financial Officer; Timothy P. Fitzgerald, Senior Vice President Operations; James B. Gaul, Senior Vice President U.S. Sales and Customer Support; Terrance J. Kapsen, Senior Vice President Marketing and Corporate Business Development; Timothy R.J. Quinn, Senior Vice President International Business Development; Michael G. Snow, Senior Vice President Advanced Technologies and Clinical Programs |
| |
|
|
|
|
|
|
| Recent Results |
| For the fiscal quarter ended January 31, 2006, revenues reached a record $6.9 million, up 37.8% from the first quarter of 2005. The company achieved double-digit year-over-year revenue growth for the seventh quarter in a row. Net income was $176,000 for the quarter, versus a net loss of $711,000 during the same period of 2005, representing the company's second consecutive quarter of profitability. The company has set the goal of achieving another year of double-digit year-over-year growth in 2006. |
| |
|
|
|
|
| Keywords |
| cardio, cardiology, respiratory, non-invasive, diagnostic systems, diagnostics, pulmonary, cardiology, early detection, spirometry, SoftwareSystems |
|
|
|
| Description |
|
Angeion Corporation (Angeion), incorporated in May 1986, is engaged in developing, manufacturing and selling medical products. Through the Company's Medical Graphics Corporation subsidiary, Angeion designs and markets non-invasive cardiorespiratory diagnostic systems that are sold under the MedGraphics and New Leaf brand and trade names. These cardiorespiratory diagnostic systems have a range of applications in healthcare, wellness, and health and fitness. Through rapid analysis of an individual's inhaled and exhaled breath, Angeion's advanced technologies provide physicians, health professionals, trainers and coaches with a non-invasive diagnostic window to view a person's overall cardiorespiratory health and fitness.
Primary MedGraphics brand products include pulmonary function (PFT) and cardiopulmonary gas exchange (GX) testing systems. All MedGraphics' products, except for certain original equipment manufacturer (OEM) products, are sold with a personal computer, full color monitor, printer and other peripherals. The Company also sells one of its cardiorespiratory diagnostic systems together with other consumable products under the New Leaf brand to consumers through health and fitness clubs, personal training studios, weight loss centers and other retail outlets. The Company sells its cardiorespiratory diagnostic systems and services to clinical research customers for use in conducting safety and efficacy clinical trial studies both in the United States and internationally.
The clinical importance ranges from prevention to early detection and effective management of a wide range of cardiopulmonary diseases such as asthma, emphysema and congestive heart failure. In the health and fitness arena, Angeion's health management solutions help individuals achieve weight management, cardiovascular fitness, and athletic performance goals through precise measurement of metabolism at rest and during exercise. |
|
| Products / Services |
Angeion's products include pulmonary function and cardiopulmonary exercise testing systems for hospitals, clinics and physician offices. The company's pulmonary function systems consist of spirometry, pulmonary function and body plethysmography. Its cardiopulmonary exercise testing systems measure fitness or conditioning levels and help physicians diagnose heart and lung diseases. The company also sells a line of health and fitness products, marketed under the New Leaf health and fitness brand, that help consumers effectively manage their weight, improve fitness or enhance athletic performance.
|
|
| Technology / Differentiation |
| Angeion designs products that assist healthcare professionals in the prevention, early detection and treatment of heart and lung disease. |
|
| Market / Customers |
Angeion's cardiorespiratory diagnostic products are sold in the pulmonary, cardiology, rehabilitation, critical care and primary care markets in more than 75 countries. Users include hospitals, university-based medical centers, clinics and physician offices of heart and lung specialists. The company's health and fitness products are marketed under the New Leaf brand and are sold to consumers primarily through personal training studios, health and fitness clubs and other exercise facilities.
|
|
| Competitors / Substitutes / Alternatives |
Competitors include SensorMedics (a division of VIASYS Healthcare Inc.) and Ferraris Respiratory (a division of Ferraris Group Plc).
|
|
| Strategy |
Angeion is focused on broadening its product portfolio to compete in a larger market. The company is also focused on providing diagnostic equipment to companies involved in clinical trials.
|
|
| Status |
| Customer acceptance of the five new MedGraphics cardiorespiratory diagnostic products introduced in 2005, including the Ultima Series, continues to grow steadily. The number of New Leaf Active Metabolic Training participants is also growing quickly.
The New Leaf procuct line, launched in 2002, is contributing significantly to revenue growth. Angeion holds 24 patents, providing a strong propritary position in its core business. |
|
|
|
| |
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members